ARTICLE | Company News
Abraxis, Antitope deal
October 11, 2010 7:00 AM UTC
Antitope will use its EpiScreen immunogenicity testing technology to profile protein therapeutics from Abraxis. Antitope will use the technology to provide preclinical assessment of the immunogenicity...